Emergent Retained Earnings vs Net Debt Analysis

0IGA Stock

11.28 0.28 2.55%

Emergent Biosolutions financial indicator trend analysis is much more than just examining Emergent Biosolutions latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Emergent Biosolutions is a good investment. Please check the relationship between Emergent Biosolutions Retained Earnings and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Retained Earnings vs Net Debt

Retained Earnings vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Emergent Biosolutions Retained Earnings account and Net Debt. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Emergent Biosolutions' Retained Earnings and Net Debt is -0.19. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Net Debt in the same time period over historical financial statements of Emergent Biosolutions, assuming nothing else is changed. The correlation between historical values of Emergent Biosolutions' Retained Earnings and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Emergent Biosolutions are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Retained Earnings i.e., Emergent Biosolutions' Retained Earnings and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.19

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Emergent Biosolutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Emergent Biosolutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.Selling General Administrative is likely to gain to about 366.2 M in 2025. Tax Provision is likely to gain to about 123.3 M in 2025

	2023	2024	2025 (projected)
Interest Expense	87.9M	101.1M	106.1M
Depreciation And Amortization	125.1M	143.9M	151.1M

Interest Expense Depreciation And Amortization

Emergent Biosolutions fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.85	0.6	0.55	0.93	0.73	0.62	0.42	0.54	0.7	0.74	0.42	0.42	0.7	0.63	0.67	0.77	0.59	0.61	0.75	0.8	0.9	0.64	0.43	0.71	0.7
Short Long Term Debt Total	0.85		0.57	0.83	0.67	0.63	0.9	0.12	0.7	0.5	0.71	0.77	0.34	0.5	0.53	0.7	0.6	0.53	0.8	0.67	0.83	0.99	0.57	0.73	0.75	0.72
Other Current Liab	0.6	0.57		0.56	0.46	0.88	0.43	0.65	0.87	0.44	0.89	0.58	-0.41	0.44	0.76	0.86	0.13	0.84	0.8	0.85	0.34	0.6	0.97	0.28	0.82	0.86
Total Current Liabilities	0.55	0.83	0.56		0.33	0.58	0.78	0.06	0.7	0.36	0.6	0.92	0.04	0.36	0.29	0.56	0.24	0.3	0.82	0.57	0.56	0.76	0.58	0.94	0.61	0.62
Total Stockholder Equity	0.93	0.67	0.46	0.33		0.67	0.37	0.52	0.35	0.79	0.58	0.17	0.48	0.79	0.52	0.45	0.76	0.44	0.43	0.65	0.73	0.74	0.54	0.23	0.49	0.48
Property Plant And Equipment Net	0.73	0.63	0.88	0.58	0.67		0.41	0.79	0.71	0.6	0.92	0.44	-0.26	0.6	0.74	0.78	0.26	0.77	0.73	0.76	0.4	0.65	0.95	0.36	0.79	0.78
Net Debt	0.62	0.9	0.43	0.78	0.37	0.41		-0.19	0.7	0.08	0.62	0.82	0.24	0.08	0.52	0.7	0.46	0.49	0.79	0.44	0.78	0.88	0.36	0.69	0.75	0.72
Retained Earnings	0.42	0.12	0.65	0.06	0.52	0.79	-0.19		0.28	0.63	0.6	-0.11	-0.38	0.63	0.45	0.38	-0.05	0.56	0.21	0.51	-0.07	0.17	0.75	-0.12	0.38	0.34
Accounts Payable	0.54	0.7	0.87	0.7	0.35	0.71	0.7	0.28		0.23	0.81	0.82	-0.29	0.23	0.72	0.87	0.15	0.77	0.95	0.72	0.55	0.72	0.79	0.44	0.83	0.86
Cash	0.7	0.5	0.44	0.36	0.79	0.6	0.08	0.63	0.23		0.38	0.15	0.33	1.0	0.14	0.18	0.45	0.22	0.28	0.66	0.38	0.53	0.57	0.3	0.2	0.18
Non Current Assets Total	0.74	0.71	0.89	0.6	0.58	0.92	0.62	0.6	0.81	0.38		0.56	-0.27	0.38	0.85	0.95	0.27	0.9	0.79	0.72	0.48	0.74	0.89	0.37	0.96	0.94
Non Currrent Assets Other	0.42	0.77	0.58	0.92	0.17	0.44	0.82	-0.11	0.82	0.15	0.56		-0.05	0.15	0.35	0.63	0.18	0.37	0.88	0.54	0.58	0.72	0.52	0.81	0.63	0.67
Other Assets	0.42	0.34	-0.41	0.04	0.48	-0.26	0.24	-0.38	-0.29	0.33	-0.27	-0.05		0.33	-0.23	-0.27	0.73	-0.37	-0.14	0.0	0.57	0.36	-0.38	0.21	-0.21	-0.21
Cash And Short Term Investments	0.7	0.5	0.44	0.36	0.79	0.6	0.08	0.63	0.23	1.0	0.38	0.15	0.33		0.14	0.18	0.45	0.22	0.28	0.66	0.38	0.53	0.57	0.3	0.2	0.18
Net Receivables	0.63	0.53	0.76	0.29	0.52	0.74	0.52	0.45	0.72	0.14	0.85	0.35	-0.23	0.14		0.9	0.36	0.9	0.68	0.59	0.51	0.59	0.72	0.02	0.86	0.88
Good Will	0.67	0.7	0.86	0.56	0.45	0.78	0.7	0.38	0.87	0.18	0.95	0.63	-0.27	0.18	0.9		0.29	0.93	0.84	0.7	0.54	0.73	0.8	0.31	0.98	0.98
Common Stock Shares Outstanding	0.77	0.6	0.13	0.24	0.76	0.26	0.46	-0.05	0.15	0.45	0.27	0.18	0.73	0.45	0.36	0.29		0.18	0.3	0.47	0.8	0.65	0.17	0.24	0.3	0.35
Non Current Liabilities Total	0.59	0.53	0.84	0.3	0.44	0.77	0.49	0.56	0.77	0.22	0.9	0.37	-0.37	0.22	0.9	0.93	0.18		0.66	0.63	0.36	0.59	0.78	0.01	0.9	0.85
Inventory	0.61	0.8	0.8	0.82	0.43	0.73	0.79	0.21	0.95	0.28	0.79	0.88	-0.14	0.28	0.68	0.84	0.3	0.66		0.73	0.68	0.8	0.76	0.61	0.82	0.85
Other Current Assets	0.75	0.67	0.85	0.57	0.65	0.76	0.44	0.51	0.72	0.66	0.72	0.54	0.0	0.66	0.59	0.7	0.47	0.63	0.73		0.52	0.7	0.85	0.38	0.66	0.72
Other Stockholder Equity	0.8	0.83	0.34	0.56	0.73	0.4	0.78	-0.07	0.55	0.38	0.48	0.58	0.57	0.38	0.51	0.54	0.8	0.36	0.68	0.52		0.87	0.32	0.48	0.56	0.57
Total Liab	0.9	0.99	0.6	0.76	0.74	0.65	0.88	0.17	0.72	0.53	0.74	0.72	0.36	0.53	0.59	0.73	0.65	0.59	0.8	0.7	0.87		0.59	0.63	0.78	0.75
Total Current Assets	0.64	0.57	0.97	0.58	0.54	0.95	0.36	0.75	0.79	0.57	0.89	0.52	-0.38	0.57	0.72	0.8	0.17	0.78	0.76	0.85	0.32	0.59		0.33	0.76	0.79
Short Term Debt	0.43	0.73	0.28	0.94	0.23	0.36	0.69	-0.12	0.44	0.3	0.37	0.81	0.21	0.3	0.02	0.31	0.24	0.01	0.61	0.38	0.48	0.63	0.33		0.38	0.39
Intangible Assets	0.71	0.75	0.82	0.61	0.49	0.79	0.75	0.38	0.83	0.2	0.96	0.63	-0.21	0.2	0.86	0.98	0.3	0.9	0.82	0.66	0.56	0.78	0.76	0.38		0.97
Common Stock	0.7	0.72	0.86	0.62	0.48	0.78	0.72	0.34	0.86	0.18	0.94	0.67	-0.21	0.18	0.88	0.98	0.35	0.85	0.85	0.72	0.57	0.75	0.79	0.39	0.97

Click cells to compare fundamentals

Emergent Biosolutions Account Relationship Matchups

Emergent Biosolutions fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.9B	3.0B	3.2B	1.8B	2.1B	1.2B
Short Long Term Debt Total	874.8M	841M	1.4B	860.2M	989.2M	1.0B
Total Stockholder Equity	1.4B	1.6B	1.4B	649.3M	746.7M	621.9M
Net Debt	253.5M	264.9M	763.2M	748.5M	860.8M	903.8M
Cash	621.3M	576.1M	642.6M	111.7M	128.5M	217.0M
Other Assets	27.1M	65.6M	1.0	171.9M	197.7M	207.6M
Cash And Short Term Investments	621.3M	576.1M	642.6M	111.7M	128.5M	217.2M
Common Stock Shares Outstanding	53.8M	54.1M	50.1M	51.2M	58.9M	41.4M
Liabilities And Stockholders Equity	2.9B	3.0B	3.2B	1.8B	2.1B	1.2B
Other Current Assets	73.2M	70.4M	57.9M	47.9M	55.1M	27.7M
Other Stockholder Equity	745.3M	677.2M	645.8M	676.7M	778.2M	817.1M
Total Liab	1.4B	1.3B	1.8B	1.2B	1.3B	1.4B
Current Deferred Revenue	131.5M	140.4M	26.4M	27.2M	31.3M	28.2M
Accumulated Other Comprehensive Income	(25.3M)	(16.1M)	3.1M	(5.7M)	(5.1M)	(5.4M)
Property Plant Equipment	567M	675.1M	828.4M	837M	962.6M	660.2M
Other Liab	200M	173.6M	131M	90.4M	81.4M	116.4M
Net Tangible Assets	80M	517.2M	789.5M	436M	501.4M	459.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Emergent Retained Earnings vs Net Debt Analysis

Retained Earnings vs Net Debt

Retained Earnings vs Net Debt Correlation Analysis

Correlation Coefficient

Retained Earnings

Net Debt

Emergent Biosolutions fundamental ratios Correlations

Emergent Biosolutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Emergent Biosolutions fundamental ratios Accounts

Also Currently Popular

Additional Tools for Emergent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Short Long Term Debt Total
Intangible Assets	+ 0.98	Good Will
Common Stock	+ 0.98	Good Will
Total Current Assets	+ 0.97	Other Current Liab
Common Stock	+ 0.97	Intangible Assets

Other Assets	- 0.41	Other Current Liab
Total Current Assets	- 0.38	Other Assets
Other Assets	- 0.38	Retained Earnings
Non Current Liabilities Total	- 0.37	Other Assets
Other Assets	- 0.29	Accounts Payable
Good Will	- 0.27	Other Assets